MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 31.357

Change

+0.10 (+0.33)%

Market Cap

N/A

Volume

1.09K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

+4.91 (+2.53%)

USD 30.45B
ACWI iShares MSCI ACWI ETF

+2.07 (+1.78%)

USD 18.45B
IBIT iShares Bitcoin Trust

+1.86 (+5.45%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

+0.15 (+0.76%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.85 (+1.59%)

USD 15.58B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 3.07B
IBTE iShares iBonds Dec 2024 Term T..

+0.01 (+0.04%)

USD 2.56B
IBTF iShares iBonds Dec 2025 Term T..

+0.02 (+0.06%)

USD 2.34B
NVDL GraniteShares 1.5x Long NVDA D..

+4.14 (+8.09%)

USD 2.05B
USCL iShares Climate Conscious & Tr..

+1.10 (+1.64%)

USD 2.01B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.27% 71% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.27% 70% C- 68% D+
Trailing 12 Months  
Capital Gain 5.55% 45% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.55% 38% F 48% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.28% 51% F 44% F
Dividend Return 0.28% 45% F 40% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 1.09% 98% N/A 100% F
Risk Adjusted Return 25.40% 53% F 59% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector